Though biologic medications have improved the treatment landscape by providing the solution to many unmet medical needs, biologics cost much more than small-molecule chemical medications. Biosimilars ...
The designation means that pharmacists can switch patients to the less-expensive version of insulin without seeking approval from the clinician. The FDA late Thursday approved the country’s first ...
Apple has filed a new patent that outlines a future device where a phone can transform into a full-fledged camera system by attaching a dedicated camera module, marking a major departure from current ...
Please provide your email address to receive an email when new articles are posted on . Simlandi is the first interchangeable, citrate-free Humira biosimilar available in a high concentration. The ...
Laptops run on rechargeable batteries, so they have one major advantage over desktop computers: portability. Obviously, there is a tradeoff. Even if you purchase a laptop with the best battery life ...
President Joe Biden’s budget proposal for fiscal 2025 includes a proposal that would allow pharmacy substitution of biosimilar drugs for the reference product, even if they are not designated as ...
Realme has revealed its Interchangeable Lens Concept phone at MWC 2025. This phone has a one-inch camera sensor that can be paired with your existing Leica camera lenses. Realme’s phone also includes ...
The Food and Drug Administration’s decision on Wednesday to approve a long-acting insulin called Semglee (insulin glargine-yfgn) as the first interchangeable biologic licensed for the U.S. market ...
Interchangeable knitting needles have revolutionized knitting for everyone, from beginners to experts. These versatile needles enable you to adjust the needle ends and cables to create any size or ...
FDA has approved Mylan Pharmaceuticals’ Semglee, the first interchangeable biosimilar insulin product for treating diabetes. On July 28, 2021, FDA approved Mylan Pharmaceuticals’ Semglee (insulin ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the first interchangeable biosimilar insulin product to improve glycemic control for children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results